Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002931063 | SCV003669606 | uncertain significance | Inborn genetic diseases | 2022-12-19 | criteria provided, single submitter | clinical testing | The c.13040C>T (p.P4347L) alteration is located in exon 52 (coding exon 52) of the KMT2C gene. This alteration results from a C to T substitution at nucleotide position 13040, causing the proline (P) at amino acid position 4347 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Department of Genetics, |
RCV003126281 | SCV003804076 | likely benign | Autism spectrum disorder | 2021-08-13 | criteria provided, single submitter | clinical testing |